Hot AI Mandate: US-based VC Interested in Early to Growth Stage Life Science Opportunities Focusing on the Midwestern US

6 Jul

A venture capital firm based in Missouri is looking to make growth-stage, equity investments in a variety of sectors, including the life sciences, typically in the $2M-$10M range. The firm prefers to lead rounds, but will also syndicate deals. The firm’s first fund closed late in 2015, and is targeting between 3 and 5 investments per year, focusing on the Midwestern United States. However, this includes all states except for those in the North East and those on the West Coast.

Within the Life Science space, the firm is primarily interested in data-driven, connected medical devices and diagnostics as well as any technology that improves drug adherence (mobile apps, devices, etc.). The firm has deep domain experience in IT and is therefore very interested in healthcare IT, such as enterprise software solutions. In addition, life science tools are also an area of interest, with one of the firm’s portfolio companies being a multiplex analyte detection platform. The firm is open to all sectors within the life sciences, with the exception of therapeutics, given the product is already FDA approved or is exempt from regulatory approval.

The firm prefers to work with experienced management teams and serial entrepreneurs, however the firm is open to working with first-time entrepreneurs. The firm prefers to lead rounds and requires a board seat along with an investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: